What is BRTX's health score?

BioRestorative Therapies, Inc. (BRTX) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BRTX's estimated fair value?

Based on our 5-year discounted cash flow model, BioRestorative Therapies, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is BRTX undervalued or overvalued?

Our model currently rates BRTX as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BRTX... Refresh in a moment for the full analysis.

BioRestorative Therapies, Inc. (BRTX)

Healthcare Inconclusive inconclusive weak

$0.38

Updated: 2026-06-04

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

58 Mixed

Relative Value

40 Weak

Capital Allocation

30 Weak

Risk

50 Mixed

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.